参附益心颗粒治疗慢性心力衰竭的安全性评价分析-safety evaluation and analysis of shenfu yixin granule in treating chronic heart failure.docxVIP

目 录摘要 ...................................................................................................................................... 1英文摘要 .................................................................................................................................. 3前言 ...................................................................................................................................... 5对象与方法 .............................................................................................................................. 61 临床资料 .................................................................................................................... 62 诊断标准 .................................................................................................................... 63 病例选择标准 ............................................................................................................ 74 分组、用药及疗程...................................................................................................... 95 安全性评价 ................................................................................................................. 96 统计学分析................................................................................................................ 11结果 .................................................................................................................................... 12讨论 .................................................................................................................................... 211 祖国医学对慢性心力衰竭的认识 ......................................................................... 212 参附益心颗粒中组方及药物分析 ......................................................................... 233 参附益心颗粒治疗慢性心力衰竭的现代医学机理 ........................................... 254 参附益心颗粒的前期研究及其安全性分析........................................................ 26结论 ..........................................................................................................